Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,512.03
(
-0.09%
)
US TECH 100
29,099.60
(
-0.38%
)
Dow Jones
50,622.94
(
0.32%
)
Brent Oil
93.25
(
-3.85%
)
Bitcoin
75,040.99
(
-1.06%
)
News Focus
News Focus
Post# of 257644
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 123024
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: io_io post# 11808

Wednesday, 06/01/2005 1:34:27 PM

Wednesday, June 01, 2005 1:34:27 PM

Post# of 257644
>>"Based on prevailing estimates, there are approximately 80,000 people in the European Union and 60,000 people in the US with HD. " Still don't understand why, with this prevalence, they allow such small trials for approval purposes?<<

The European and U.S. ATryn trials test individuals with HD who undergo elective surgery or childbirth. Only a small fraction of the 60-80K patient pool will have such a procedure scheduled during any given time period.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today